Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes.

In contrast, recipients in the nonadherence group showed a decreasing trend in mean eGFR during the follow-up period (follow-up baseline: 55.44 ± 18.39 mL/min/1.73 m2, follow-up 3 months: 55.43 ± 19.36 mL/min/1.73 m2, follow-up 6 months: 54.88 ± 19.53 mL/min/1.73 m2, follow-up 9 months: 53.51 ± 20.08 mL/min/1.73 m2, follow-up 12 months: 51.99 ± 20.49 mL/min/1.73 m2), and the difference between the mean eGFR at follow-up 9 months and follow-up 12 months and the mean eGFR at follow-up baseline was statistically significant ( p = 0.009, p < 0.001, respectively).

also in 47,180 other papers